正在加载视频...

视频加载失败

DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇

34,166 次观看 • 7 个月前 •via X (Twitter)

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频